chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: M
Vaccine: COVID19
Symptoms: Myalgia, Somnolence
Clinical narrative: Drowsiness (both first and second vaccine effects similar); Mild muscle soreness (both first and second vaccine effects similar); This is a spontaneous report received from a contactable consumer, the patient. A 72-Years-Old male patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot no: UNKNOWN) via an unspecified route and on an unspecified anatomical sight on 19Mar2021, at 14:45 PM as an unknown single dose for COVID-19 immunisation. The patients medical history and concomitant medications were not reported. It was reported that, prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested positive for COVID-19. It was reported that the patient did not received any other vaccines within 4 weeks prior to the COVID vaccine. On 20Mar2021, at 11:00 AM the patient experienced drowsiness and mild muscle soreness, the patient reported that both first and second vaccine effects similar. The patient did not receive any treatment for events. The clinical outcome of drowsiness and mild muscle soreness was recovering at the time of report. No follow-up attempts are possible. Information about lot number cannot be obtained.
Age: 20.0
Sex: F
Vaccine: COVID19
Symptoms: Dyspnoea
Clinical narrative: became shirt of breath about 5minutes after getting the shot; This is spontaneous report from contactable consumer, the patient. A 20-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER8727), via an unspecified route of administration, in left arm on 17Mar2021 at 11:00, (at the age of 20-year-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Patient have no allergies to medications, food, or other products. Patient did not receive any concomitant medications. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient was not tested positive for COVID-19. On 17Mar2021 at 11:15, the patient experienced short of breath about 5 minutes after getting the shot. The events didn't result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of shortness of breath was resolving. No follow-up attempts are possible. No further information is expected.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Nasopharyngitis
Clinical narrative: Feel tired and worn out.; Head cold; This is a spontaneous report from a contactable consumer, the patient. A 36-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE BIONTECH, Lot number: EN6297) via an unspecified route of administration in the left arm on 16Mar2021 at 14:00 (at the age of 36-years-old) as a single dose for COVID-19 immunisation. Medical history included generalized anxiety disorder and depression. Concomitant medications included buspirone hydrochloride (BUSPAR), duloxetine (CYMBALTA), clonazepam (KLONOPIN), acetaminophen, dextromethorphan, guaifenesin, phenylephrine (ALKA SELTZER) and fexofenadine hydrochloride (ALLEGRA), for unknown indications. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient felt like tired and worn out, like a head cold, on 18Mar2021. The patient did not receive any treatment for the reported events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of feel tired and worn out and  head cold were unknown.   No follow-up attempts are needed. No further information is expected.
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Myalgia
Clinical narrative: fatigue; muscle aches; This is a spontaneous report from a contactable consumer, the patient. A 44-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6203), via an unspecified route of administration in the left arm on 18Mar2021 at 10:00 (at the age of 44-years-old), as a single dose for COVID-19 immunisation. Medical history included hypertension. Allergies to medications, food, or other products reported to avocado. Concomitant medications included amlodipine (MANUFACTURER UNKNOWN), multivitamins (MANUFACTURER UNKNOWN), both from unknown dates for unspecified indications. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: unknown), via an unspecified route of administration on 25Feb2021 at 10:00 (at the age of 44-years-old), as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 19Mar2021 at 15:00, the patient experienced fatigue and muscle aches. The patient received treatment for the events fatigue and muscle aches which included ibuprofen . The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The outcome of the fatigue and muscle aches was recovered on an unknown date in Mar2021.   No follow-up attempts are needed. No further information is expected.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Vision blurred
Clinical narrative: Blurry Vision; This is a spontaneous report from a contactable consumer, the patient. A 79-year-old female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6204) via an unspecified route of administration in the right arm on 16Mar2021 at 10:45 (at the age of 79-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Concomitant medications were not reported. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN5318) via an unspecified route of administration on right arm on an 19Feb2021 at 14:00 as a single dose for COVID-19 immunisation. On 17Mar2021 at 12:00, the patient experienced blurry vision. The patient did not receive any treatment for the reported event. The clinical outcome of the blurry vision was resolved on an unspecified date in 2021.  No follow-up attempts are needed. No further information is expected
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Epistaxis, Fatigue, Vaccination site pain
Clinical narrative: Unusual slight nose bleed; tired; chills; minor injection site pain; This is a spontaneous report from a contactable consumer, the patient. A 75-years-old male patient received his first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: unknown), via an unspecified route of administration in the right arm on 19Mar2021 at 09:00 (at the age of 75-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient was not tested for COVID-19. On 19Mar2021 at 19:00 the patient experienced an unusual slight nose bleed in the night after, the patient experienced tired, chills and minor injection site pain. The patient received tylenol (MANUFACTURER UNKNOWN) for the treatment of events. It was reported that adverse events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events unusual slight nose bleed, tired, chills and vaccination site pain were recovered on an unknown date.   Information about the lot number cannot be obtained. No further information is expected.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: Headache every day since the 1st vaccine.; This is a spontaneous report received from a contactable consumer, the patient. A 52-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EL 3249) via an unspecified route of administration in the left arm on 19Jan2021 (at the age of 52-year-old) and second dose of as a single dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EL 9269) via an unspecified route of administration in the left arm on 09Feb2021 for COVID-19 immunisation. Medical history. The patient was not allergic to food, medications and other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included vyvanse (MANUFACTURER UNKNOWN), propananol (MANUFACTURER UNKNOWN) and estrogen patch (MANUFACTURER UNKNOWN) and progesterone (MANUFACTURER UNKNOWN) on unspecified date for unknown indication. On an unknown date in 2021 the patient had experienced patient had a headache every day since the first vaccine. The patient did not receive treatment for the reported events. Event resulted in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. The clinical outcome of the event headache was not resolved at the time of this report.   No follow-up attempts are possible. No further information is expected
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Confusional state, Lethargy, Pain, Rash
Clinical narrative: Brain fog; Extreme lethargy; Body aches; Fine rash on head/neck/extremities; Chills; This is a spontaneous report from a contactable healthcare professional, the patient. A 41-years-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: UNKNOWN) via an unspecified route of administration on left arm on 18Mar2021 at 11:00 (at the age of 41-year-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19 diagnosed prior to vaccination. Patient had no allergy to medications, food, or other products. Concomitant medications included tazorac 0.1% (MANUFACTURER UNKNOWN) on face only from an unknown date for unknown indication. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. Since the vaccination, the patient had not been tested for COVID-19. On 19Mar2021 at 00:00, the patient experienced mental confusion, lethargy, chills, ache and fine rash on head, neck and extremities. No treatment was received by the patient for the adverse events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of events mental confusion, lethargy, chills, ache, rash were not resolved at the time of this report.   Information about lot/batch number cannot be obtained. No further information is expected.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Peripheral swelling, Swelling
Clinical narrative: Swelling in armpit; Swelling neck; This is a spontaneous report from a contactable consumer, the patient. A 50-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER6213), via an unspecified route of administration in right arm on 18Mar2021 at 16:45 (at the age of 50-year-old), as a single dose for COVID-19 immunisation. Medical history was not reported. The patient had no known allergies. Concomitant medication included  DUPIXENT for unknown indication, from unknown date and unknown if ongoing. The patient did not receive any other vaccines within 4 weeks prior to vaccination. Prior to vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 20Mar2021 at 08:00, the patient experienced swelling in armpit and neck on the same side where the shot was administered. It was unknown if the patient received any treatment for the adverse event. The clinical outcome of the event swelling in armpit and neck was not resolved at the time of reporting.  No follow-up attempts are needed. No further information is expected.
Age: 56.0
Sex: M
Vaccine: COVID19
Symptoms: Contusion, Heart rate abnormal, Hypoaesthesia, Pain, Paraesthesia
Clinical narrative: Swelling; Bruising and hardness; Tingling; Numbness sensations; Achy and uneasy feeling through the forearm to date; Rapid heart rate; This is a spontaneous report from a contactable consumer, the patient. A 55-year-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6206) via an unspecified route of administration in the left arm on 09Mar2021 at 00:30 (at the age of 56-year-old) as a single dose for COVID-19 immunisation. The medical history included allergic to penicillin. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested positive for COVID-19. The patient was not taking any concomitant medications. The patient had not received any other vaccines within 4 weeks prior to the COVID vaccine. The patient did not receive any other medications within 2 weeks of vaccination. On 11Mar2021, the patient experienced left hand ring finger, swelling, bruising, hardness, tingling/numbness sensations. The patient also experienced achy and uneasy feeling through the forearm to-date. The patient had continued swelling and hardness in the area and experienced rapid heart rate. The patient did not receive any treatment for the reported events. The adverse event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events swelling, bruising and hardness, tingling, numbness sensations, achy and uneasy feeling through the forearm to-date and rapid heart rate was not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 56.0
Sex: M
Vaccine: COVID19
Symptoms: Swelling
Clinical narrative: Swelling; Bruising and hardness; Tingling; Numbness sensations; Achy and uneasy feeling through the forearm to date; Rapid heart rate; This is a spontaneous report from a contactable consumer, the patient. A 55-year-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6206) via an unspecified route of administration in the left arm on 09Mar2021 at 00:30 (at the age of 56-year-old) as a single dose for COVID-19 immunisation. The medical history included allergic to penicillin. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested positive for COVID-19. The patient was not taking any concomitant medications. The patient had not received any other vaccines within 4 weeks prior to the COVID vaccine. The patient did not receive any other medications within 2 weeks of vaccination. On 11Mar2021, the patient experienced left hand ring finger, swelling, bruising, hardness, tingling/numbness sensations. The patient also experienced achy and uneasy feeling through the forearm to-date. The patient had continued swelling and hardness in the area and experienced rapid heart rate. The patient did not receive any treatment for the reported events. The adverse event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events swelling, bruising and hardness, tingling, numbness sensations, achy and uneasy feeling through the forearm to-date and rapid heart rate was not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test, Vaccination site pain
Clinical narrative: Soreness of injection site; This is a spontaneous report received from a contactable healthcare professional. A 42-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN1206) via intramuscular route of administration in the left arm on 19Mar2021 at 07:15 (at the age of 42-years-old) as a single dose for COVID-19 immunisation. Medical history included lupus, mitral valve prolapse, thrombocytopenia and pulmonary fibrosis. The patient did not have any allergies to medications, food or other products. Concomitant medications included hydroxychloroquine (MANUFACTURER UNKNOWN), VASCEPA, XARELTO, folic acid (MANUFACTURER UNKNOWN), pantoprazole (MANUFACTURER UNKNOWN) and daily vit; all for unknown indications, from unknown date and unknown if ongoing. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the vaccination. On 17Mar2021, the patient underwent saliva PCR test and had tested negative. On 19Mar2021 at 07:15, the patient experienced soreness of injection site. The adverse event resulted in doctor or other healthcare professional office or clinic visit. The patient did not receive any treatment for the event. The clinical outcome of the event soreness of injection site was resolved at the time of reporting. No follow-up attempts are needed. No further information is expected.
Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: Rash pruritic
Clinical narrative: Itchy red rash around neck and sides of face.; Red rash; This is a spontaneous report received from a contactable consumer. A 78-years-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot no: EP 7534), via an unspecified route of administration on the arm left on 17Mar2021 at 11:30, as single dose for COVID-19 immunisation. Medical history was reported as heart disorder, diabetes, high blood pressure and allergy to bee sting and venom. Concomitant medication was reported as atorvastatin (MANUFACTURER UNKNOWN) at a dose of 80 milligram, glimepiride (UNKNOWN MANUFACTURER) at a dose of 02 milligram and atenolol (UNKNOWN MANUFACTURER) at a dose of 25 milligram for an unknown indication. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. The patient did not receive any other vaccines within 2 weeks prior to the COVID-19 vaccine. On 19Mar2021 7:30, the patient experienced itchy red rash around neck and sides of face and red rash. The patient did not received treatment for the reported events. Patient did not visit to the doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care for adverse event. The clinical outcome of events itchy rash was not recovered. The clinical outcome of red rash was unknown.   No follow-up attempts are possible. No further information is expected.
Age: 53.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness, Fatigue, Palpitations
Clinical narrative: Slight palpitations and a little dizziness and tiredness.; Little dizziness; Tiredness; This is a spontaneous report from a contactable consumer, the patient. A 53-years-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: unknown), via an unspecified route of administration in the left arm on 20Mar2021 at 13:45 (at the age of 53-years-old) as a single dose for COVID-19 immunisation. The patient medical history included high blood pressure and high cholesterol. Concomitant medications were not reported. The patient was allergic to Gluten. Prior to vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. The patient did not receive any other vaccines within for weeks prior to the COVID-19 vaccine. The patient had received medications within 2 weeks of vaccination, the details of which were not given. The patient experienced slight palpitations and a little dizziness and tiredness on 20Mar2021 at 02:45. The patient did not receive any treatment for palpitations, dizziness and tiredness. The clinical outcome of the events slight palpitations, little dizziness and tiredness were not recovered.   Information about lot number cannot be obtained. No further information expected.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Fatigue, Headache, Myalgia, Neck pain
Clinical narrative: Pain on movement, especially trying to reach up, in right arm around and below injection site; Ache in shoulder and neck; Ache in shoulder and neck; Headache; Pain on movement, especially trying to reach up, in my right arm around and below injection site; Fatigue; Muscle soreness; This is a spontaneous report from a contactable consumer, the patient. A 59-year-old non-pregnant female patient received unspecified dose of BNT162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE BIONTECH, Lot number: UNKNOWN) via an unspecified route of administration in the right arm on 20Mar2021 at 10:45 (at the age of 59-year-old) as a single dose for COVID-19 immunisation. The patient's medical history included diabetes 2, fibromyalgia and arthritis on an unknown date. It was also reported that the patient was allergic to blue dyes in food and medicine on an unknown date. Concomitant medications were not provided. Patient was receiving prescribed medications within 2 weeks of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. Prior to vaccination, the patient was not been diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 20Mar2021 at 12:15, patient experienced muscle soreness, pain on movement especially trying to reach up in right arm around and below injection site, ache in shoulder and neck, headache and fatigue. Treatment received for the events muscle soreness, pain on movement especially trying to reach up in right arm around and below injection site, ache in shoulder and neck, headache and fatigue were unknown. The outcome of the events muscle soreness, pain on movement especially trying to reach up in right arm around and below injection site, ache in shoulder and neck, headache and fatigue was not recovered at the time of report.   Information about lot/batch number cannot be obtained. No further information is expected.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site movement impairment, Vaccination site pain
Clinical narrative: Pain on movement, especially trying to reach up, in right arm around and below injection site; Ache in shoulder and neck; Ache in shoulder and neck; Headache; Pain on movement, especially trying to reach up, in my right arm around and below injection site; Fatigue; Muscle soreness; This is a spontaneous report from a contactable consumer, the patient. A 59-year-old non-pregnant female patient received unspecified dose of BNT162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE BIONTECH, Lot number: UNKNOWN) via an unspecified route of administration in the right arm on 20Mar2021 at 10:45 (at the age of 59-year-old) as a single dose for COVID-19 immunisation. The patient's medical history included diabetes 2, fibromyalgia and arthritis on an unknown date. It was also reported that the patient was allergic to blue dyes in food and medicine on an unknown date. Concomitant medications were not provided. Patient was receiving prescribed medications within 2 weeks of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. Prior to vaccination, the patient was not been diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 20Mar2021 at 12:15, patient experienced muscle soreness, pain on movement especially trying to reach up in right arm around and below injection site, ache in shoulder and neck, headache and fatigue. Treatment received for the events muscle soreness, pain on movement especially trying to reach up in right arm around and below injection site, ache in shoulder and neck, headache and fatigue were unknown. The outcome of the events muscle soreness, pain on movement especially trying to reach up in right arm around and below injection site, ache in shoulder and neck, headache and fatigue was not recovered at the time of report.   Information about lot/batch number cannot be obtained. No further information is expected.
Age: 42.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Arthralgia, Neck pain, Pain, SARS-CoV-2 test
Clinical narrative: Pain on the right side of neck; Pain on the right shoulder; Radiating pain; This is a spontaneous report received from a contactable consumer. A 42 years old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6201), via an unspecified route of administration in the left arm on 17Mar2021, at 10:00 (at the age of 42 years old), as a single dose, for COVID-19 immunisation. Medical history included crohns disease. The patient received Lomotil (MANUFACTURER UNKNOWN), Infliximab (MANUFACTURER UNKNOWN) medication within two weeks of vaccination. The patient did not have symptoms associated with COVID-19. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within two weeks prior to the vaccination. Since the vaccination, the patient had been tested for COVID-19.  The patient had a nasal swab PCR test on 26Feb2021, 27Feb2021 and 03Mar2021 which resulted negative. On 18Mar2021, at 09:00 (day after the injection in left arm), the patient started feeling pain on the right side of neck and shoulder. Patient thought he slept wrong side but whenever that happened the pain would go away within a day. This has not resolved this time. The patient has a radiating pain (about a 5 with spikes to 8 if he moves it wrong) about mid neck down through shoulder and partially down back over his right shoulder blade. The level of pain had been fluctuating. Sometimes it was a dull pain and other times was extremely sharp pain in neck and shoulder. It has not gotten even a little better since it started two days ago. Patient was not sure if it was related to the vaccine. As a therapeutic measure patient had been self-medicating with heating pad with temporary relief and also received Advil (MANUFACTURER UNKNOWN). The events did not result in doctor or other healthcare professional office/clinic visit. The clinical outcome of event pain on right side of neck, pain on right shoulder and radiating pain were not recovered.   No follow-up attempts are needed. No further information is expected.
Age: 42.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Arthralgia, Contraindication to vaccination, Movement disorder, Neck pain, Pain
Clinical narrative: Pain on the right side of neck; Pain on the right shoulder; Radiating pain; This is a spontaneous report received from a contactable consumer. A 42 years old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6201), via an unspecified route of administration in the left arm on 17Mar2021, at 10:00 (at the age of 42 years old), as a single dose, for COVID-19 immunisation. Medical history included crohns disease. The patient received Lomotil (MANUFACTURER UNKNOWN), Infliximab (MANUFACTURER UNKNOWN) medication within two weeks of vaccination. The patient did not have symptoms associated with COVID-19. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within two weeks prior to the vaccination. Since the vaccination, the patient had been tested for COVID-19.  The patient had a nasal swab PCR test on 26Feb2021, 27Feb2021 and 03Mar2021 which resulted negative. On 18Mar2021, at 09:00 (day after the injection in left arm), the patient started feeling pain on the right side of neck and shoulder. Patient thought he slept wrong side but whenever that happened the pain would go away within a day. This has not resolved this time. The patient has a radiating pain (about a 5 with spikes to 8 if he moves it wrong) about mid neck down through shoulder and partially down back over his right shoulder blade. The level of pain had been fluctuating. Sometimes it was a dull pain and other times was extremely sharp pain in neck and shoulder. It has not gotten even a little better since it started two days ago. Patient was not sure if it was related to the vaccine. As a therapeutic measure patient had been self-medicating with heating pad with temporary relief and also received Advil (MANUFACTURER UNKNOWN). The events did not result in doctor or other healthcare professional office/clinic visit. The clinical outcome of event pain on right side of neck, pain on right shoulder and radiating pain were not recovered.   No follow-up attempts are needed. No further information is expected.
Age: 42.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: SARS-CoV-2 test
Clinical narrative: Pain on the right side of neck; Pain on the right shoulder; Radiating pain; This is a spontaneous report received from a contactable consumer. A 42 years old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6201), via an unspecified route of administration in the left arm on 17Mar2021, at 10:00 (at the age of 42 years old), as a single dose, for COVID-19 immunisation. Medical history included crohns disease. The patient received Lomotil (MANUFACTURER UNKNOWN), Infliximab (MANUFACTURER UNKNOWN) medication within two weeks of vaccination. The patient did not have symptoms associated with COVID-19. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within two weeks prior to the vaccination. Since the vaccination, the patient had been tested for COVID-19.  The patient had a nasal swab PCR test on 26Feb2021, 27Feb2021 and 03Mar2021 which resulted negative. On 18Mar2021, at 09:00 (day after the injection in left arm), the patient started feeling pain on the right side of neck and shoulder. Patient thought he slept wrong side but whenever that happened the pain would go away within a day. This has not resolved this time. The patient has a radiating pain (about a 5 with spikes to 8 if he moves it wrong) about mid neck down through shoulder and partially down back over his right shoulder blade. The level of pain had been fluctuating. Sometimes it was a dull pain and other times was extremely sharp pain in neck and shoulder. It has not gotten even a little better since it started two days ago. Patient was not sure if it was related to the vaccine. As a therapeutic measure patient had been self-medicating with heating pad with temporary relief and also received Advil (MANUFACTURER UNKNOWN). The events did not result in doctor or other healthcare professional office/clinic visit. The clinical outcome of event pain on right side of neck, pain on right shoulder and radiating pain were not recovered.   No follow-up attempts are needed. No further information is expected.
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Vision blurred
Clinical narrative: Blurred vision; This is a spontaneous report received from a contactable consumer, the patient and contactable health care professional. A 75-year-old male patient received her first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: unknown) via an unspecified route of administration in right arm on 18Mar2021 at 10:00 (at the age of 75-years-old) as a single dose, for COVID-19 immunisation. Medical history included kidney failure, heart, asthma and chronic obstructive pulmonary disease (COPD). The patient received unspecified medications in two weeks prior to COVID vaccine. The patient did not receive any other vaccines within 4 weeks prior to COVID vaccine. The patient had no allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested positive for COVID-19. On 19Mar2021, the patient had blurred vision for three hours during dialysis, which resulted in doctor or other healthcare professional office or clinic visit. No treatment was given for the event. The clinical outcome of event blurred vision was not recovered at the time of this report. No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 84.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Confusional state, Fatigue, Pyrexia
Clinical narrative: Fever; Chills; Extreme fatigue; Confusion; This is a spontaneous report received from a contactable consumer, the patient. An 84-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; lot number: EZ6207) in the right arm via an unspecified route on 19Mar2021 at 03:30 PM as a single dose (at the age of 84-years-old) for COVID-19 immunisation. Medical history included congestive heart failure. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; lot number: EN6200) in the right arm via an unspecified route on 23Feb2021 at 03:30 PM as a single dose (at the age of 84-years-old) for COVID-19 immunisation. The patient did not receive any other vaccination within four weeks prior to the COVID-19 vaccine. The patient had received other medications within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 20Mar2021 at 10:00 AM, the patient had fever, chills, extreme fatigue, confusion. The patient did not receive any treatment for this event and the events didn't resulted in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events fever, chills, extreme fatigue, confusion was recovering at the time of report.   No follow-up attempts are needed. No further information is expected.
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Pain, Pain in extremity
Clinical narrative: Light aches; Arm pain; Tired; This is a spontaneous report received from a contactable consumer, the patient. A 28-year-old female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: unknown) via an unspecified route of administration on the left arm on 19Mar2021 at 14:00 (at the age of 28 years), as single dose for COVID-19 immunisation. Medical history included allergic to penicillin. Concomitant therapies included ibuprofen (MANUFACTURER UNKNOWN), LUTERA and NAUZENE from an unknown date for unknown indication. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. Since the vaccination, the patient has not tested for COVID-19. The patient experienced arm pain, tired and light aches on 19Mar2021 at 16:00. The patient did not receive any treatment for the reported events. The clinical outcome of arm pain, tired and light aches were recovering.   Information about lot/batch number cannot be obtained. No further information is expected.
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Headache, Pyrexia
Clinical narrative: Fever; Extreme fatigue; Headache; This is a spontaneous report from a contactable consumer, the patient. A 59-year-old male patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EZ6207) via an unspecified route of administration, on 19Mar2021, at 15:30, (at the age of 58 years) via unspecified route of administration, on left arm, as a single dose for COVID-19 immunisation. Medical history included high blood pressure and milk allergy. Concomitant medications were unspecified. The patient did not receive any other vaccine within 4 weeks prior to the COVID-19 vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6201) via an unspecified route of administration, on 26Feb2021, at 15:30, on left arm, as a single dose for COVID-19 immunisation. On 20Mar2021, at 12:00, the patient experienced fever, fatigue and headache. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care The clinical outcome of event fever, fatigue and headache was recovering at the time of this report. No follow-up attempts are possible. No further information is expected.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Rash, Rash pruritic
Clinical narrative: Small bumps that itch on legs, back and arms; Small bumps that itch on legs, back and arms; This is a spontaneous report received from a contactable consumer, the patient. A 62 years-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6201 via an unspecified route of in left arm on 27Feb2021 at 15:00 (at the age of 62-years-old) as a single dose for COVID-19 immunisation. The patient was allergic to penicillin, tetracycline, sulfur and general anaesthesia. The patient medical history was reported as degenerated disc disease, neurogenic claudication and hypertension. Concomitant medication reported as gabapentin (MANUFACTURER UNKNOWN), cyclobenzaprine (MANUFACTURER UNKNOWN), metoprolol (MANUFACTURER UNKNOWN) from an unknown date and it is not reported if its ongoing. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EL3247) via an unspecified route of administration on left arm on 06Feb2021 at15:00, (at the age of 62-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient did not have symptoms associated with COVID-19. Since the vaccination, the patient was not tested positive for COVID-19. The patient did not receive any other vaccines within two weeks prior to the vaccination. On 03Mar2021 (4 days after dose 2 vaccination) at 04:00, the patient experienced small itchy bumps on legs, back and arms which broken out into rash. Patient was still fighting rash with Benadryl and bumps with a cream which was suggested by the dermatologist. The patient received Benadryl and cream as a therapeutic measure for the events. The events not resulted in doctor or other healthcare professional office/clinic visit. The clinical outcome of event itchy rash and rash all over was not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Fatigue, Headache
Clinical narrative: Joints hurt a lot; Headache; Tired; This is a spontaneous report received from a contactable consumer, the patient. A 33-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; Lot number: UNKNOWN), via an unspecified route of administration in the right arm on 19Mar2021 at 08:30 (at the age of 33-years-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19. Concomitant medications included prenatal iron (MANUFACTURER UNKNOWN) and ARMOUR 90 mg, for unknown indications from unknown dates. The patient previously received aripiprazole (ABILIFY) and experienced allergy. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 20Mar2021 at 10:00, the patient's joints were hurting a lot. She had a headache and was very tired. She had COVID less than one month ago and it felt like the beginning of it again. The adverse events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the adverse events joints hurt a lot, headache and tired. The clinical outcomes of the events joints hurt a lot, headache and tired were recovering at the time of the report.   Information about lot/batch number cannot be obtained. No further information is expected.
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Chills, Pyrexia
Clinical narrative: Chills; Lack of energy; slight fever; This is a spontaneous report received from a non-contactable consumer, the patient. A 61-years-old male patient received unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; lot number: EN6205) via an unspecified route of administration in the right arm on 12mar2021 at 1:30 for COVID-19 immunisation.  TMedical history included asthma and sinus. Concomitant medications included antibiotics received within two weeks. The patient did not receive any vaccination within four weeks prior to the COVID-19 vaccine. and prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient experienced Chills, lack of energy and slight fever on 20Mar2021 at 9.00.The patient did not receive any treatment for reported events. The clinical outcome of the events Chills, lack of energy, slight fever was not recovered .   No follow-up attempts are needed. No further information is expected.
Age: 28.0
Sex: M
Vaccine: COVID19
Symptoms: Pruritus, Rash, Rash erythematous, Rash papular, Skin warm
Clinical narrative: felt warm in forehead; forehead was red; rash in forehead/elbow and chest; little bumps in forehead; itch in forehead/elbows and chest; This is a spontaneous report received from a contactable consumer, the patient. A 28 years-old male patient received his first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6207) via an unspecified route administration in left arm on 19Mar2021 at 11:00, (at the age of 28-years-old) as a single dose, for COVID-19 immunisation. There was no medical history and no known allergies. The concomitant medications included ibuprofen (MANUFACTURER UNKNOWN) that started on an unknown date for unknown indication and unknown if ongoing. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested positive for COVID-19. The patient did not receive any other vaccines within two weeks prior to the vaccination. On 19Mar2021 at 11:30 (30-45 minutes after getting the vaccine), the patient started to get a rash in his forehead; At first, it felt warm and he did not notice it, until his wife pointed out that his forehead was red. After an hour, his forehead started to itch and after scratching it, little bumps started to emerged on his forehead. Later that night, the patient began to feel itchy in his elbows and chest. It was also reported, that the rash on the elbow and chest was smaller compared to the one in patients forehead. On 20Mar2021, (today, was the day after) the patient still had the rash in his forehead, elbow and chest. No treatment was received for the events. The clinical outcome of events rash in forehead/elbow and chest, felt warm in forehead, forehead was red, little bumps in forehead, itch in forehead/elbows and chest were not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Dysgeusia
Clinical narrative: Intense metallic taste in mouth; This is a spontaneous report received from a contactable consumer, the patient. A 29-year-old non-pregnant female patient received her first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER8730), via an unspecified route of administration in the right arm on 20Mar2021 at 13:30 (at the age of 29-years-old), as a single dose for COVID-19 immunisation. The patient had no medical history reported. The patient did not have any allergies to medications, food, or other products. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Concomitant medication included etonogestrel; ethinyl estradiol (NUVARING) for an unknown indication on an unknown date. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 20Mar2021 at 14:00, the patient experienced intense metallic taste in mouth. The patient did not receive treatment for the event intense metallic taste in mouth. The clinical outcome of the event intense metallic taste in mouth was not recovered.  No follow-up attempts are needed. No further information is expected.
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Hyperhidrosis, Pain, SARS-CoV-2 test
Clinical narrative: Sweats; Body aches; Chill, as if had flu; This is a spontaneous report from a contactable consumer, the patient. A 61-year-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EL9269) via an unspecified route of administration on left arm on 03Mar2021 at 13:15 (at the age of 61-year-old) as a single for COVID-19 immunisation. Medical history included liver transplant, lymphoma and spleen removed due to lymphoma. The patient had not received any other vaccination within 4 weeks. Patient had taken other medications within two weeks prior to vaccination which were too many to list. The patient had no allergies to medications, food, or other products. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient had SARS-CoV-2 test (nasal swab) on 23Feb2021 and resulted negative. On 04Mar2021 at 18:00, the patient experienced sweats, body aches, chill as if the patient had flu. No treatment was received by the patient for the adverse events. The adverse events did not result in doctor or other healthcare professional office or clinic visit and emergency room or department or urgent care. The clinical outcome of the events sweats, body aches, chill was not resolved at the time of this report.   No follow-up attempts are possible. No further information is expected.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Pain, Pyrexia, Vaccination site pain
Clinical narrative: chills; Fever 101.5; sore at injection site; slight swelling at injection site; Achiness; This is a spontaneous report received from a contactable consumer, the patient. A 65-years-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EP7534) via unspecified route of administration on left arm on 19Mar2021 at 15:15 (at the age of 65-year-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Patient had known allergies with sulfa drugs and zest bar soap. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient was not tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Concomitant medications included multivitamins (MANUFACTURER UNKNOWN), ZESTRIL, HYDRODIURIL started from an unknown date for an unknown indication. On 20Mar2021 at 12:15, the patient experienced chills, achiness, fever at 101.5(units unspecified), soreness and slight swelling at injection site. Lab tests and procedures included body temperature test on 20Mar2021 at 12:15 and the result was 101.5 (units unspecified). The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care visit. No therapeutic measures taken for the reported events. The clinical outcome of the events chills, ache, fever, vaccination site pain and vaccination site swelling were not recovered at the time of this report. No follow-up attempts are needed. No further information is expected